CRISPR Therapeutics AG (CRSP): Price and Financial Metrics

CRISPR Therapeutics AG (CRSP): $55.05

1.11 (-1.98%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

C

Add CRSP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#233 of 362

in industry

CRSP Price/Volume Stats

Current price $55.05 52-week high $91.10
Prev. close $56.16 52-week low $37.55
Day low $54.28 Volume 1,766,100
Day high $57.50 Avg. volume 1,845,097
50-day MA $72.73 Dividend yield N/A
200-day MA $59.58 Market Cap 4.67B

CRSP Stock Price Chart Interactive Chart >


CRISPR Therapeutics AG (CRSP) Company Bio


CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The company is based in Basel, Switzerland.


CRSP Latest News Stream


Event/Time News Detail
Loading, please wait...

CRSP Latest Social Stream


Loading social stream, please wait...

View Full CRSP Social Stream

Latest CRSP News From Around the Web

Below are the latest news stories about CRISPR THERAPEUTICS AG that investors may wish to consider to help them evaluate CRSP as an investment opportunity.

AI and Automation Leaders for 2024: 7 Stocks to Stay Ahead of the Robot Uprising

It’s time for investors to ditch the search for the mythical crystal ball and instead embrace the algorithms when deciphering the best AI stock for your needs.

Josh Enomoto on InvestorPlace | December 30, 2023

3 Healthcare Technology Stocks to Improve Lives in 2024

Healthcare technology is one of 2024's top investment trends, and investors looking for long-term upside should check out these top stocks.

Jeremy Flint on InvestorPlace | December 25, 2023

Could CRISPR Therapeutics Stock Help You Become a Millionaire?

There are plenty of reasons to be optimistic about CRISPR's future.

Yahoo | December 22, 2023

Up More Than 60% in 2023, Is It Too Late to Buy This Soaring Biotech Stock?

The FDA's recent approval of CRISPR Therapeutics' first therapy is a step in the right direction.

Yahoo | December 22, 2023

6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy

Should you buy CRISPR's stock on the dip?

Yahoo | December 21, 2023

Read More 'CRSP' Stories Here

CRSP Price Returns

1-mo -26.11%
3-mo -11.20%
6-mo 37.28%
1-year 5.85%
3-year -55.94%
5-year 47.79%
YTD -12.06%
2023 54.00%
2022 -46.36%
2021 -50.51%
2020 151.39%
2019 113.18%

Continue Researching CRSP

Here are a few links from around the web to help you further your research on CRISPR Therapeutics AG's stock as an investment opportunity:

CRISPR Therapeutics AG (CRSP) Stock Price | Nasdaq
CRISPR Therapeutics AG (CRSP) Stock Quote, History and News - Yahoo Finance
CRISPR Therapeutics AG (CRSP) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!